The World Health Organization declared the Ebola outbreak in the Democratic Republic of Congo and Uganda a Public Health Emergency of International Concern on May 17, 2026.
This designation triggers international coordination and resources to contain a virus that currently lacks an approved vaccine or treatment. The emergency status reflects the risk of the disease crossing borders and overwhelming local health systems.
The outbreak is centered in the Ituri province of the eastern Democratic Republic of Congo and neighboring Uganda [1, 2]. Director-General Tedros Adhanom Ghebreyesus said the declaration followed reports of more than 300 suspected cases [1, 4].
Health officials have confirmed 88 deaths [4], though some reports place the toll at nearly 90 [5]. The crisis is exacerbated by the presence of the Bundibugyo Ebola virus strain [6]. This specific strain is considered rare and complicates the medical response.
The WHO said that infections have already spread among healthcare workers [4, 6]. The lack of a targeted vaccine for the Bundibugyo strain increases the vulnerability of those treating patients in the affected regions.
Medical teams are working to stabilize the region and prevent further transmission into neighboring territories. The organization is coordinating with regional governments to deploy emergency personnel and supplies to the Ituri province and Ugandan border zones [1, 2].
“The WHO declared the Ebola outbreak in the Democratic Republic of Congo and Uganda a Public Health Emergency of International Concern.”
The declaration of a Public Health Emergency of International Concern (PHEIC) is the WHO's highest alert level. Because the Bundibugyo strain is rare and lacks a dedicated vaccine, the outbreak cannot be managed with the standard protocols used for more common Ebola strains. This necessitates a global mobilization of diagnostics and experimental therapeutics to prevent the virus from becoming endemic in Central Africa.
